Literature DB >> 34404916

Characterization of integration frequency and insertion sites of adenovirus DNA into mouse liver genomic DNA following intravenous injection.

Zhibin Wang1, Philip J Troilo2, Thomas G Griffiths2, Laural B Harper2, Amy B Barnum2, Stephen J Pacchione2, Cindy J Pauley2, Jose A Lebron2, Jayanthi Wolf2, Brian J Ledwith2.   

Abstract

While generally referred to as "non-integrating" vectors, adenovirus vectors have the potential to integrate into host DNA via random, illegitimate (nonhomologous) recombination. The present study provides a quantitative assessment of the potential integration frequency of adenovirus 5 (Ad5)-based vectors following intravenous injection in mice, a common route of administration in gene therapy applications particularly for transgene expression in liver. We examined the uptake level and persistence in liver of first generation (FG) and helper-dependent (HD) Ad5 vectors containing the mouse leptin transgene. As expected, the persistence of the HD vector was markedly higher than that of the FG vector. For both vectors, the majority of the vector DNA remained extrachromosomal and predominantly in the form of episomal monomers. However, using a quantitative gel-purification-based integration assay, a portion of the detectable vector was found to be associated with high molecular weight (HMW) genomic DNA, indicating potential integration with a frequency of up to ~44 and 7000 integration events per μg cellular genomic DNA (or ~0.0003 and 0.05 integrations per cell, respectively) for the FG and HD Ad5 vectors, respectively, following intravenous injection of 1 × 1011 virus particles. To confirm integration occurred (versus residual episomal vector DNA co-purifying with genomic DNA), we characterized nine independent integration events using Repeat-Anchored Integration Capture (RAIC) PCR. Sequencing of the insertion sites suggests that both of the vectors integrate randomly, but within short segments of homology between the vector breakpoint and the insertion site. Eight of the nine integrations were in intergenic DNA and one was within an intron. These findings represent the first quantitative assessment and characterization of Ad5 vector integration following intravenous administration in vivo in wild-type mice.
© 2021. Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, N.J., U.S.A., under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34404916     DOI: 10.1038/s41434-021-00278-2

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  3 in total

Review 1.  A new concept in (adenoviral) oncogenesis: integration of foreign DNA and its consequences.

Authors:  W Doerfler
Journal:  Biochim Biophys Acta       Date:  1996-10-09

Review 2.  Gene therapy clinical trials worldwide to 2017: An update.

Authors:  Samantha L Ginn; Anais K Amaya; Ian E Alexander; Michael Edelstein; Mohammad R Abedi
Journal:  J Gene Med       Date:  2018-04-19       Impact factor: 4.565

3.  Clonal origin of adenovirus type 12-induced hamster tumors: nonspecific chromosomal integration sites of viral DNA.

Authors:  K Hilger-Eversheim; W Doerfler
Journal:  Cancer Res       Date:  1997-07-15       Impact factor: 12.701

  3 in total
  1 in total

1.  Medical student acceptance on gene therapy to increase children's well-being with genetic diseases: a study in Indonesia.

Authors:  Dimas Setyanto; Annette d'Arqom; Danti Nur Indiastuti; Ema Qurnianingsih; Nurina Hasanatuludhhiyah; Safira Nur Izzah; Mhd Zamal Nasution; Junaidah Yusof
Journal:  Future Sci OA       Date:  2022-05-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.